Naren Manoj

Title: Naren Manoj: Innovator in Artificial Intelligence for Prostate Cancer Prediction

Introduction

Naren Manoj is a prominent inventor based in Mountain View, CA (US). He has made significant contributions to the field of artificial intelligence, particularly in the medical domain. His innovative work focuses on predicting prostate cancer outcomes, which has the potential to improve patient care and treatment strategies.

Latest Patents

Naren Manoj holds a patent for an innovative method titled "Artificial intelligence prediction of prostate cancer outcomes." This method involves receiving an image of prostate tissue and assigning Gleason pattern values to specific regions within the image using an artificial intelligence Gleason grading model. The model is trained to identify Gleason patterns on a patch-by-patch basis in a prostate tissue image. The process includes determining relative areal proportions of the Gleason patterns within the image and assigning a risk score or risk group value based on these proportions. Ultimately, the method outputs the risk score or risk group value, providing valuable insights for medical professionals.

Career Highlights

Naren Manoj is currently associated with Verily Life Sciences LLC, a company dedicated to advancing healthcare through technology and data science. His work at Verily emphasizes the integration of artificial intelligence in medical diagnostics, showcasing his commitment to leveraging technology for better health outcomes.

Collaborations

Naren has collaborated with notable colleagues, including Craig Mermel and Yun Liu. These partnerships reflect a collaborative spirit in the pursuit of innovative solutions in healthcare.

Conclusion

Naren Manoj's contributions to artificial intelligence in predicting prostate cancer outcomes highlight the intersection of technology and medicine. His innovative patent and work at Verily Life Sciences LLC demonstrate his dedication to improving patient care through advanced technological solutions.